About DiaMedica Therapeutics Inc.
https://www.diamedica.comDiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases.
CEO
Dietrich John Pauls MBA
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2018-11-15 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Showing Top 3 of 32
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
COOPERMAN LEON G
Shares:3.27M
Value:$28.12M
BLACKROCK, INC.
Shares:1.68M
Value:$14.43M
MILLENNIUM MANAGEMENT LLC
Shares:1.19M
Value:$10.21M
Summary
Showing Top 3 of 84
About DiaMedica Therapeutics Inc.
https://www.diamedica.comDiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $9.02M ▲ | $-8.62M ▼ | 0% | $-0.17 ▲ | $-8.6M ▼ |
| Q2-2025 | $0 | $8.01M ▼ | $-7.7M ▲ | 0% | $-0.18 | $-8M ▲ |
| Q1-2025 | $0 | $8.14M ▼ | $-7.71M ▲ | 0% | $-0.18 | $-8.13M ▼ |
| Q4-2024 | $0 | $8.41M ▲ | $-7.9M ▼ | 0% | $-0.18 ▼ | $-7.88M ▼ |
| Q3-2024 | $0 | $6.88M | $-6.27M | 0% | $-0.15 | $-6.87M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $55.32M ▲ | $57.05M ▲ | $5.42M ▲ | $51.62M ▲ |
| Q2-2025 | $30.04M ▼ | $31.47M ▼ | $4.3M ▼ | $27.17M ▼ |
| Q1-2025 | $36.32M ▼ | $38.83M ▼ | $4.88M ▼ | $33.95M ▼ |
| Q4-2024 | $44.15M ▼ | $46.34M ▼ | $5.63M ▲ | $40.72M ▼ |
| Q3-2024 | $50.2M | $52.52M | $4.56M | $47.96M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-8.62M ▼ | $-6.6M ▲ | $-26.21M ▼ | $32.01M ▲ | $-783K ▼ | $-6.62M ▲ |
| Q2-2025 | $-7.7M ▲ | $-7.6M ▼ | $8.96M ▲ | $161K ▲ | $1.52M ▲ | $-7.6M ▼ |
| Q1-2025 | $-7.71M ▲ | $-7.15M ▼ | $6.62M ▲ | $91K ▼ | $-436K ▲ | $-7.16M ▼ |
| Q4-2024 | $-7.9M ▼ | $-6.43M ▼ | $5.21M ▲ | $120K ▼ | $-1.11M ▲ | $-6.44M ▼ |
| Q3-2024 | $-6.27M | $-4.47M | $-5.58M | $123K | $-9.93M | $-4.48M |
CEO
Dietrich John Pauls MBA
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2018-11-15 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Showing Top 3 of 32
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
COOPERMAN LEON G
Shares:3.27M
Value:$28.12M
BLACKROCK, INC.
Shares:1.68M
Value:$14.43M
MILLENNIUM MANAGEMENT LLC
Shares:1.19M
Value:$10.21M
Summary
Showing Top 3 of 84